Page last updated: 2024-10-30

manidipine and Hypertension, Malignant

manidipine has been researched along with Hypertension, Malignant in 2 studies

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohta, Y1
Chikugo, T1
Suzuki, T1
Chichibu, S1
Okamura, M1
Konishi, Y1
Nishimura, M1
Negoro, N1
Umetani, N1
Inoue, T1
Kanayama, Y1
Takeda, T1

Other Studies

2 other studies available for manidipine and Hypertension, Malignant

ArticleYear
Electroencephalographic evaluation of the therapeutic efficiency of antihypertensive agents on M-SHRSP.
    Clinical and experimental pharmacology & physiology. Supplement, 1995, Volume: 22, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Wei

1995
Platelet-derived growth factor gene expression in the kidney of malignant hypertension.
    Blood pressure. Supplement, 1992, Volume: 3

    Topics: Animals; Base Sequence; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models,

1992